M. J. Bywater

710 total citations
33 papers, 558 citations indexed

About

M. J. Bywater is a scholar working on Pharmacology, Molecular Medicine and Epidemiology. According to data from OpenAlex, M. J. Bywater has authored 33 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pharmacology, 19 papers in Molecular Medicine and 8 papers in Epidemiology. Recurrent topics in M. J. Bywater's work include Antibiotics Pharmacokinetics and Efficacy (20 papers), Antibiotic Resistance in Bacteria (19 papers) and Antibiotic Use and Resistance (7 papers). M. J. Bywater is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (20 papers), Antibiotic Resistance in Bacteria (19 papers) and Antibiotic Use and Resistance (7 papers). M. J. Bywater collaborates with scholars based in United Kingdom, Switzerland and Zimbabwe. M. J. Bywater's co-authors include H. A. Holt, D. S. Reeves, D. S. Reeves, L. O. White, Richard Bax, Robert A. Wise, Alasdair MacGowan, R. M. J. Ings, J. M. Broughall and M.G. Elder and has published in prestigious journals such as The Lancet, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

M. J. Bywater

33 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. J. Bywater United Kingdom 16 337 228 159 82 81 33 558
Neu Hc United States 12 275 0.8× 215 0.9× 135 0.8× 66 0.8× 50 0.6× 41 520
K. A. Bedford United Kingdom 13 448 1.3× 328 1.4× 174 1.1× 97 1.2× 52 0.6× 22 672
T. A. Pursiano United States 10 368 1.1× 278 1.2× 121 0.8× 116 1.4× 53 0.7× 16 548
F. Leitner United States 12 394 1.2× 259 1.1× 138 0.9× 118 1.4× 49 0.6× 29 562
R. E. Buck United States 9 318 0.9× 194 0.9× 114 0.7× 82 1.0× 45 0.6× 16 452
Inga Odenholt-Tornqvist Sweden 8 328 1.0× 247 1.1× 147 0.9× 49 0.6× 62 0.8× 9 436
P. Acred United Kingdom 14 311 0.9× 236 1.0× 160 1.0× 136 1.7× 70 0.9× 30 675
M. Husson Belgium 13 205 0.6× 176 0.8× 165 1.0× 88 1.1× 96 1.2× 35 499
M Misiek United States 11 346 1.0× 226 1.0× 102 0.6× 113 1.4× 37 0.5× 26 497
Barbara LeBlanc United States 15 364 1.1× 305 1.3× 177 1.1× 107 1.3× 124 1.5× 45 629

Countries citing papers authored by M. J. Bywater

Since Specialization
Citations

This map shows the geographic impact of M. J. Bywater's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. J. Bywater with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. J. Bywater more than expected).

Fields of papers citing papers by M. J. Bywater

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. J. Bywater. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. J. Bywater. The network helps show where M. J. Bywater may publish in the future.

Co-authorship network of co-authors of M. J. Bywater

This figure shows the co-authorship network connecting the top 25 collaborators of M. J. Bywater. A scholar is included among the top collaborators of M. J. Bywater based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. J. Bywater. M. J. Bywater is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reeves, D. S., H. A. Holt, M. J. Bywater, & Alasdair MacGowan. (1993). The activity of piperacillin/tazobactam against clinical isolates collected in 20 UK centres and the design of a disc test for susceptibility testing. Journal of Antimicrobial Chemotherapy. 32(1). 51–61. 7 indexed citations
2.
Reeves, D. S., M. J. Bywater, & H. A. Holt. (1993). The activity of cefpirome and ten other antibacterial agents against 2858 clinical isolates collected from 20 centres. Journal of Antimicrobial Chemotherapy. 31(3). 345–362. 26 indexed citations
3.
Rogers, S, M. J. Bywater, & D. S. Reeves. (1991). Audit of turn-around times in a microbiology laboratory.. Journal of Clinical Pathology. 44(3). 257–258. 7 indexed citations
4.
MacGowan, Alasdair, H. A. Holt, M. J. Bywater, & D. S. Reeves. (1990). In vitro antimicrobial susceptibility ofListeria monocytogenes isolated in the UK and otherListeria species. European Journal of Clinical Microbiology & Infectious Diseases. 9(10). 767–770. 28 indexed citations
5.
Holt, H. A., M. J. Bywater, & D. S. Reeves. (1990). In-vitro activity of cefpodoxime against 1834 isolates from domiciliary infections at 20 UK centres. Journal of Antimicrobial Chemotherapy. 26(suppl E). 7–12. 15 indexed citations
6.
Lovering, A. M., et al.. (1988). Resistance of bacterial pathogens to four aminoglycosides and six other antibacterials and prevalence of aminoglycoside modifying enzymes, in 20 UK centres. Journal of Antimicrobial Chemotherapy. 22(6). 823–839. 17 indexed citations
7.
Reeves, D. S., M. J. Bywater, & H. A. Holt. (1987). Activity in vitro of CGP 31608, a new penem antibacterial agent. Journal of Antimicrobial Chemotherapy. 20(2). 165–178. 5 indexed citations
8.
Reeves, D. S., M. J. Bywater, H. A. Holt, & L. O. White. (1984). In-vitro studies with ciprofloxacin, a new 4-quinolone compound. Journal of Antimicrobial Chemotherapy. 13(4). 333–346. 105 indexed citations
9.
Reeves, D. S., H. A. Holt, & M. J. Bywater. (1983). Comparative activity in vitro of ceftazidime and nine other antibacterial agents. Infection. 11(S1). S3–S11. 7 indexed citations
10.
Reeves, D. S., M. J. Bywater, & H. A. Holt. (1982). Comparative in-vitro activity of Sch 29482, a new penem antibiotic. Journal of Antimicrobial Chemotherapy. 9(suppl C). 31–40. 4 indexed citations
11.
Reeves, D. S., H. A. Holt, M. J. Bywater, & J. L. Bidwell. (1982). Comparative activity in vitro of piperacillin. Journal of Antimicrobial Chemotherapy. 9(suppl B). 59–74. 6 indexed citations
12.
Reeves, D. S., M. J. Bywater, & H. A. Holt. (1981). Antibacterial activity of the monobactam SQ 26,776 against antibiotic resistant enterobacteria, including Serratia spp.. Journal of Antimicrobial Chemotherapy. 8(suppl E). 57–68. 19 indexed citations
13.
Bywater, M. J., et al.. (1980). Comparison of sensititre dried microtitration trays with a standard agar method for determination of minimum inhibitory concentrations of antimicrobial agents. Antimicrobial Agents and Chemotherapy. 18(6). 844–852. 15 indexed citations
14.
Broughall, J. M., M. J. Bywater, H. A. Holt, & D. S. Reeves. (1979). Bactericidal or bacteristatic effects of two sulphonamide plus trimethoprim preparations in human urine. Infection. 7(3). 113–118. 1 indexed citations
15.
Reeves, D. S., J. M. Broughall, M. J. Bywater, H. A. Holt, & H Vergin. (1979). Pharmacokinetics of tetroxoprim and sulphadiazine in human volunteers. Journal of Antimicrobial Chemotherapy. 5(Supplement B). 119–138. 7 indexed citations
16.
Broughall, J. M., M. J. Bywater, H. A. Holt, & D. S. Reeves. (1979). Stabilization of cephalosporins in serum and plasma. Journal of Antimicrobial Chemotherapy. 5(4). 471–472. 6 indexed citations
17.
Reeves, D. S., M. J. Bywater, & H. A. Holt. (1978). Antibacterial synergism between beta-lactam antibiotics: Results using clavulanic acid (BRL. 14151) with amoxycillin, carbenicillin or cephaloridine. Infection. 6(S1). S9–S16. 18 indexed citations
18.
Elder, M.G., M. J. Bywater, & D. S. Reeves. (1977). PELVIC TISSUE AND SERUM CONCENTRATIONS OF VARIOUS ANTIBIOTICS GIVEN AS PRE‐OPERATIVE MEDICATION. BJOG An International Journal of Obstetrics & Gynaecology. 84(12). 887–893. 16 indexed citations
19.
Andrews, J. M., M. J. Bywater, A.M. Emmerson, et al.. (1976). The Prevalence of Ampicillin, Cephalosporin and Sulphonamide Resistance amongst Urinary Tract Pathogens. PubMed. 20(5). 271–277. 5 indexed citations
20.
Reeves, D. S., Robert A. Wise, & M. J. Bywater. (1975). A laboratory evaluation of a novel (β-lactam antibiotic mecillinam. Journal of Antimicrobial Chemotherapy. 1(3). 337–344. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neu Hc Breakdown of academic impact, for papers by K. A. Bedford Breakdown of academic impact, for papers by T. A. Pursiano Breakdown of academic impact, for papers by F. Leitner Breakdown of academic impact, for papers by R. E. Buck Breakdown of academic impact, for papers by Inga Odenholt-Tornqvist Breakdown of academic impact, for papers by P. Acred Breakdown of academic impact, for papers by M. Husson Breakdown of academic impact, for papers by M Misiek Breakdown of academic impact, for papers by Barbara LeBlanc
Rankless by CCL
2026